David Montecalvo

David Montecalvo has a diverse work experience in various leadership roles in the medical and business sectors. David is currently the Chief Executive Officer and Board Director at RBC Medical Innovations since February 2023. Prior to this, they held the same positions at Sterling Medical Devices from February 2023 and served as a Board Director from October 2022. David has also worked as an Executive Advisor at Ampersand Capital Partners starting from October 2022. Additionally, David Montecalvo was an Advisory Board Member at Olin Business School at Washington University since February 2017.

In terms of their earlier experiences, they served as an Advisor To Chief Executive Officer at West Pharmaceutical Services from May 2022 to July 2022. David held several roles at Medtronic, including Vice President - Contract Manufacturing Operations, Vice President, Operations Business Integration, Vice President of Product Development, Vice President of Global Operations, and Sr. Director Operations, between 2006 and 2016.

David Montecalvo has a Bachelor of Science (BS) degree in Biomedical Engineering from Case Western Reserve University. David also holds a Master of Business Administration (MBA) degree in Venture Management/Finance from the University of St. Thomas - Opus College of Business. Additionally, they have completed a program in Leading Global Businesses from Harvard Business School Executive Education. Montecalvo also possesses Six Sigma Black Belt certification, although the institution and date of obtaining this certification are not specified.